Cargando…
Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease
Induced pluripotent stem cells (iPSCs) have recapitulated several aspects of Parkinson’s disease (PD), but most iPSCs are derived from familial cases, which account for only about 15% of patients. Thus, while the emphasis has justifiably been on using iPSCs to model rare familial cases, models for t...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841660/ https://www.ncbi.nlm.nih.gov/pubmed/29513666 http://dx.doi.org/10.1371/journal.pone.0192497 |
_version_ | 1783304780381159424 |
---|---|
author | Marrone, Lara Bus, Christine Schöndorf, David Fitzgerald, Julia Catherine Kübler, Manuela Schmid, Benjamin Reinhardt, Peter Reinhardt, Lydia Deleidi, Michela Levin, Tanya Meixner, Andrea Klink, Barbara Glatza, Michael Gloeckner, Christian Johannes Gasser, Thomas Sterneckert, Jared |
author_facet | Marrone, Lara Bus, Christine Schöndorf, David Fitzgerald, Julia Catherine Kübler, Manuela Schmid, Benjamin Reinhardt, Peter Reinhardt, Lydia Deleidi, Michela Levin, Tanya Meixner, Andrea Klink, Barbara Glatza, Michael Gloeckner, Christian Johannes Gasser, Thomas Sterneckert, Jared |
author_sort | Marrone, Lara |
collection | PubMed |
description | Induced pluripotent stem cells (iPSCs) have recapitulated several aspects of Parkinson’s disease (PD), but most iPSCs are derived from familial cases, which account for only about 15% of patients. Thus, while the emphasis has justifiably been on using iPSCs to model rare familial cases, models for the most common forms of PD are critically lacking. Here, we report the generation of an iPSC-based model of idiopathic PD (iPD) with or without RS1491923, which is a common risk variant in the LRRK2 locus. Consistent with GWA studies, we found large variability in our datasets. However, iPSC-derived neurons carrying the risk allele emerged for displaying subtle disturbances of cellular degradative systems, in line with familial PD models. We also observed that treatment with the LRRK2 inhibitor CZC-25146 slightly reduced a marker of aSYN pathology in all iPD lines. Future iPSC-based studies may need to be structured similarly to large GWA studies in order to obtain relevant statistical power. However, results from this pilot study suggest that iPSC-based modeling represents an attractive way to investigate idiopathic diseases. |
format | Online Article Text |
id | pubmed-5841660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-58416602018-03-23 Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease Marrone, Lara Bus, Christine Schöndorf, David Fitzgerald, Julia Catherine Kübler, Manuela Schmid, Benjamin Reinhardt, Peter Reinhardt, Lydia Deleidi, Michela Levin, Tanya Meixner, Andrea Klink, Barbara Glatza, Michael Gloeckner, Christian Johannes Gasser, Thomas Sterneckert, Jared PLoS One Research Article Induced pluripotent stem cells (iPSCs) have recapitulated several aspects of Parkinson’s disease (PD), but most iPSCs are derived from familial cases, which account for only about 15% of patients. Thus, while the emphasis has justifiably been on using iPSCs to model rare familial cases, models for the most common forms of PD are critically lacking. Here, we report the generation of an iPSC-based model of idiopathic PD (iPD) with or without RS1491923, which is a common risk variant in the LRRK2 locus. Consistent with GWA studies, we found large variability in our datasets. However, iPSC-derived neurons carrying the risk allele emerged for displaying subtle disturbances of cellular degradative systems, in line with familial PD models. We also observed that treatment with the LRRK2 inhibitor CZC-25146 slightly reduced a marker of aSYN pathology in all iPD lines. Future iPSC-based studies may need to be structured similarly to large GWA studies in order to obtain relevant statistical power. However, results from this pilot study suggest that iPSC-based modeling represents an attractive way to investigate idiopathic diseases. Public Library of Science 2018-03-07 /pmc/articles/PMC5841660/ /pubmed/29513666 http://dx.doi.org/10.1371/journal.pone.0192497 Text en © 2018 Marrone et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Marrone, Lara Bus, Christine Schöndorf, David Fitzgerald, Julia Catherine Kübler, Manuela Schmid, Benjamin Reinhardt, Peter Reinhardt, Lydia Deleidi, Michela Levin, Tanya Meixner, Andrea Klink, Barbara Glatza, Michael Gloeckner, Christian Johannes Gasser, Thomas Sterneckert, Jared Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease |
title | Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease |
title_full | Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease |
title_fullStr | Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease |
title_full_unstemmed | Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease |
title_short | Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease |
title_sort | generation of ipscs carrying a common lrrk2 risk allele for in vitro modeling of idiopathic parkinson's disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841660/ https://www.ncbi.nlm.nih.gov/pubmed/29513666 http://dx.doi.org/10.1371/journal.pone.0192497 |
work_keys_str_mv | AT marronelara generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT buschristine generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT schondorfdavid generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT fitzgeraldjuliacatherine generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT kublermanuela generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT schmidbenjamin generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT reinhardtpeter generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT reinhardtlydia generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT deleidimichela generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT levintanya generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT meixnerandrea generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT klinkbarbara generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT glatzamichael generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT gloecknerchristianjohannes generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT gasserthomas generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease AT sterneckertjared generationofipscscarryingacommonlrrk2riskalleleforinvitromodelingofidiopathicparkinsonsdisease |